What is KALA stock price today?

KALA (Kala Bio Inc) stock is trading at $0.20 as of the latest market data. Stock prices update in real-time during market hours (9:30 AM - 4:00 PM ET).

Is KALA stock going up or down today?

KALA stock price movements are influenced by market conditions, news, earnings reports, and investor sentiment. Check our live dashboard for real-time price changes and technical indicators.

Should I buy KALA stock now?

The decision to buy KALA depends on your investment strategy, risk tolerance, and financial goals. Our AI analysis evaluates fundamentals, valuation metrics, growth prospects, and market conditions to help inform your decision.

Is KALA a buy, hold, or sell right now?

Our AI-powered analysis provides buy/hold/sell recommendations for KALA based on multiple factors including valuation, growth metrics, technical indicators, and analyst consensus. Visit our dashboard for the latest recommendation.

Is KALA stock overvalued or undervalued?

Use our DCF valuation calculator to determine if KALA is overvalued or undervalued based on fundamental analysis and future cash flow projections.

What is KALA's P/E ratio?

P/E ratio data for KALA will be available after the company reports earnings. Visit our dashboard for the latest financial metrics.

What is KALA's market cap?

KALA (Kala Bio Inc) has a market capitalization of $0.21 billion, making it a small-cap stock.

What is KALA's price to book ratio?

KALA trades at a price-to-book (P/B) ratio of 1.98, which compares the stock price to the company's book value per share. A P/B below 1.0 may indicate undervaluation, while above 3.0 may suggest premium pricing.

Does KALA pay dividends?

KALA does not currently pay dividends. Many growth companies reinvest profits into the business rather than paying dividends.

What is KALA's dividend yield?

KALA does not currently pay dividends or dividend data is not available. Check our dashboard for the latest information.

Is KALA stock a good long-term investment?

KALA's long-term investment potential depends on sustainable competitive advantages, revenue growth, profitability, management quality, and industry dynamics. Our AI analysis evaluates these factors to assess long-term prospects.

What is KALA's revenue growth rate?

KALA has shown revenue growth of -1.0% over recent periods. Consistent revenue growth is a key indicator of business health and competitive positioning.

Profitability metrics for KALA are available on our dashboard with complete income statement analysis.

What are the risks of investing in KALA?

Key risks for KALA include market volatility, competitive pressures, regulatory changes, economic conditions, execution risks, and company-specific factors. Our AI analysis identifies material risks and their potential impact on valuation.

How does KALA compare to its competitors?

Compare KALA to industry peers on our dashboard using metrics like P/E ratio, revenue growth, profit margins, market share, and valuation multiples. Competitive analysis helps contextualize KALA's performance and positioning.

What is KALA's stock price target for 2026?

Our AI model provides price targets for KALA based on fundamental analysis: Bull case $0.26 (+30%), Base case $0.23 (+15%), Bear case $0.18 (-10%). Visit our prediction page for detailed forecasts.

What do analysts say about KALA?

Wall Street analysts provide ratings (buy/hold/sell) and price targets for KALA. Our dashboard aggregates analyst consensus, target prices, and recent upgrades/downgrades to help you understand professional sentiment.

When is KALA's next earnings report?

KALA reports earnings quarterly. Check our dashboard for the upcoming earnings date, analyst estimates for revenue and EPS, and historical earnings performance. Earnings reports often drive significant stock price movements.

KALA - Kala Bio Inc

NYSE * Health Care * Pharmaceuticals

$0.20

$-0.03 (-11.96%)

About Kala Bio Inc

KALA BIO, Inc. a clinical-stage biopharmaceutical company, engages in the research, development, and commercialization of therapies for rare and severe eye diseases. The company's lead product candidates include KPI-012, which is in Phase 2b clinical trial for the treatment of persistent corneal epithelial defects; and limbal stem cell deficiency and other rare corneal diseases. Its preclinical development product consists of KPI-014 for the treatment of rare inherited retinal diseases. The company was formerly known as Kala Pharmaceuticals, Inc. and changed its name to KALA BIO, Inc. in August 2023. KALA BIO, Inc. was incorporated in 2009 and is headquartered in Arlington, Massachusetts.

KALA Key Statistics

Market Cap

$205.78M

P/B Ratio

1.98

EPS

$-5.64

Revenue Growth

-1.0%

Employees

How KALA Compares to Peers

KALA is the smallest among peers, which may offer higher growth potential

P/E Rank

N/A

of 1

Margin Rank

N/A

of 1

Growth Rank

of 2

Size Rank

of 2

Company	Market Cap	P/E	Growth	Margin	Compare
KALA(This stock)	$205.78M	N/A	-1%	0.0%	-
AMZNAmazon Com	$2.68T	34.7	0%	0.1%	vs AMZN

Kala Bio Inc Company Information

Headquarters: Massachusetts; U.S.A
Website: www.kalarx.com
Sector: Health Care
Industry: Pharmaceuticals

Data Updated: April 16, 2026 at 6:30 PM EDT

Ready to invest in KALA?

Commission-free trading available. Affiliate links.

KALA Lician Score

5% confidence

4.0/10

Neutral

KALA has a Lician Score of 4/10 (Average). Areas of concern: Growth.

value

5.0

growth

2.0

quality

5.0

momentum

5.0

safety

5.0

The Lician Score is a comprehensive 1-10 rating that evaluates KALAacross five key dimensions: Value (valuation relative to sector),Growth (revenue and earnings trajectory),Quality (profitability and balance sheet strength),Momentum (price trends and analyst sentiment), andSafety (volatility and risk metrics).

KALA Financial Snowflake

5-axis analysis across key investment dimensions

4.4/10

Neutral

5.0

Value

Valuation vs. sector peers

2.0

Growth

Revenue & earnings trajectory

5.0

Quality

Profitability & moat strength

5.0

Momentum

Price trends & analyst sentiment

5.0

Safety

Financial stability & risk

Upcoming Events for KALA

Dashboard

Enter a ticker to analyze